To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PPATTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
328 supporting clones for gene PPAT back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA006659   .a 92 to 666 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AA092319   .a 744 to 1020 1 to 273       273/280
(97 %)
14 diff
(95.0 %id)
AA374212 lung .d 4250 to 4565 1 to 318       318/318
(100 %)
4 diff
(98.8 %id)
AB209246 brain .d 700 to 4743 1 to 4044   tiling clone,   4044/4044
(100 %)
1 diff
(100.0 %id)
BP199785 brain .a 770 to 1343 1 to 574       574/582
(98 %)
4 diff
(99.4 %id)
AK222759 Liver .a 105 to 1782 1 to 1678 I242V     1678/1678
(100 %)
2 diff
(99.9 %id)
AK290942   .a 189 to 2225 1 to 2037       2037/2037
(100 %)
2 diff
(100.0 %id)
AK312297 cerebellum .a 68 to 1756 1 to 1689       1689/1689
(100 %)
0 diff
(100 %id)
DA032419   .a 105 to 659 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
AW370807 breast .l-u 1 to 483 15 to 499 exact tiling clone,   485/503
(96 %)
14 diff
(97.3 %id)
AW818201 stomach .d 1161 to 1440 299 to 20       280/300
(93 %)
0 diff
(100 %id)
AW956000   .d 4251 to 4735 1 to 485       485/597
(81 %)
2 diff
(99.7 %id)
BC004200 Muscle, rhabdomyosarcoma .a 172 to 2233 1 to 2062   available from MGC, AAA   2062/2062
(100 %)
1 diff
(100.0 %id)
BF172190 blood .a 2146 to 2271 1 to 123       123/123
(100 %)
8 diff
(93.5 %id)
BF172646 blood .a 205 to 474 1 to 269       269/269
(100 %)
18 diff
(93.4 %id)
DA040388 bladder .a 187 to 735 2 to 551   capped   550/550
(100 %)
2 diff
(99.7 %id)
DA053817   .a 183 to 806 2 to 625   capped   624/624
(100 %)
1 diff
(99.9 %id)
BQ303187 breast .a 398 to 1011 613 to 1       613/647
(94 %)
3 diff
(99.6 %id)
DA095951 cerebellum .a 69 to 629 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA168488 amygdala .a 79 to 656 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA194228 amygdala .a 187 to 763 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA203255 brain .a 106 to 689 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA208988 brain .a 190 to 703 2 to 516   capped   515/515
(100 %)
2 diff
(99.7 %id)
DA211261 brain .a 187 to 752 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA216248 brain .a 180 to 660 2 to 482   capped   481/481
(100 %)
2 diff
(99.6 %id)
DA223348 brain .a 180 to 740 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
DA231063 brain .a 69 to 604 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DA299276 hippocampus .a 69 to 628 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA319189 hippocampus .a 69 to 634 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA330417 hippocampus .g 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
DA383115 thalamus .a 187 to 742 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA409986 thalamus .k-u 1 to 567 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BX095410 carcinoid, lung .j-u 1 to 560 10 to 569   tiling clone,   560/580
(96 %)
1 diff
(99.9 %id)
BX100085 liver and spleen .d 4102 to 4746 653 to 7     Submitted on the opposite strand 647/653
(99 %)
0 diff
(100 %id)
BX282402 embryonal carcinoma, cell line, testis .a 207 to 672 1 to 466       466/466
(100 %)
0 diff
(100 %id)
F04194 brain, total brain .a 3442 to 3743 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
F07938 brain, total brain .a 2325 to 2603 1 to 279       279/279
(100 %)
0 diff
(100 %id)
CB127798 cervix, Uterine .a 1657 to 2341 1 to 678       678/678
(100 %)
5 diff
(99.3 %id)
CN312123 embryonic stem cells, cell lines H1, H7, andH9 .a 2084 to 2511 1 to 428       428/428
(100 %)
0 diff
(100 %id)
CN312124 embryonic stem cells, cell lines H1, H7, andH9 .a 434 to 1113 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
CN312125 embryonic stem cells, cell lines H1, H7, andH9 .a 82 to 792 1 to 712       712/712
(100 %)
3 diff
(99.6 %id)
CN312126 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1031 to 1289 1 to 259       259/259
(100 %)
1 diff
(99.7 %id)
CN312127 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 945 to 1355 1 to 411       411/411
(100 %)
1 diff
(99.8 %id)
CN312128 embryonic stem cells, cell lines H1, H7, andH9 .a 80 to 640 1 to 561       561/561
(100 %)
2 diff
(99.7 %id)
CN312129 embryonic stem cells, DMSO-treated H9 cellline .a 1570 to 1962 1 to 394       394/394
(100 %)
1 diff
(99.8 %id)
CN313744 embryonic stem cells, cell lines H1, H7, andH9 .d 1508 to 2109 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
CR592110 Neuroblastoma Cot 25-normalized .d 3975 to 4714 1 to 740       740/740
(100 %)
0 diff
(100 %id)
CR596411 T cells (Jurkat cell line) Cot10-normalized .d 3361 to 4643 1 to 1283       1283/1283
(100 %)
0 diff
(100 %id)
CR599321 Placenta Cot 25-normalized .a 1868 to 3326 1 to 1459   tiling clone,   1459/1459
(100 %)
0 diff
(100 %id)
AL526071 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 3975 to 4746 1 to 771   tiling clone,   771/771
(100 %)
2 diff
(99.8 %id)
AL527870 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2153 to 3229 1066 to 1       1066/1073
(99 %)
20 diff
(98.2 %id)
AL527871 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 83 to 1092 1 to 1009       1009/1114
(90 %)
6 diff
(99.5 %id)
BX443686 T cells (Jurkat cell line) .a 144 to 819 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
BX345143 Placenta Cot 25-normalized .a 132 to 989 1 to 848       850/873
(97 %)
25 diff
(97.2 %id)
BX356678 Placenta Cot 25-normalized .d 3616 to 4715 1091 to 1       1091/1177
(92 %)
67 diff
(94.4 %id)
BX373149 Placenta Cot 25-normalized .d 3882 to 4739 857 to 1       857/858
(99 %)
12 diff
(98.7 %id)
AL544437 placenta, Placenta Cot 25-normalized .a 196 to 553 1 to 358       358/358
(100 %)
4 diff
(98.9 %id)
AL570566 placenta, Placenta Cot 25-normalized .a 2739 to 3704 962 to 1       962/1022
(94 %)
17 diff
(98.4 %id)
AL552303 placenta, Placenta Cot 25-normalized .a 1868 to 2793 1 to 921       921/1002
(91 %)
49 diff
(95.2 %id)
BX327972 Placenta Cot 25-normalized .d 3411 to 4326 1 to 914       914/916
(99 %)
11 diff
(98.8 %id)
BX370273   .d 3716 to 4642 1 to 914       914/914
(100 %)
30 diff
(96.8 %id)
BX373897   .d 3853 to 4740 893 to 1       893/917
(97 %)
22 diff
(97.7 %id)
BX382966   .d 4126 to 4689 587 to 24       745/785
(94 %)
29 diff
(96.4 %id)
BX382967   .d 3361 to 4297 1 to 934       934/994
(93 %)
43 diff
(95.7 %id)
DA456984 tongue, tumor tissue .a 179 to 725 2 to 548   capped   547/547
(100 %)
3 diff
(99.5 %id)
DA457923 tongue, tumor tissue .a 69 to 637 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CU446384 epidermis .j-u 460 to 879 26 to 446   tiling clone,   421/452
(93 %)
8 diff
(98.3 %id)
CV026166 mixed .a 203 to 843 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
D13757   .a 82 to 2233 1 to 2153   tiling clone,   2153/2153
(100 %)
2 diff
(100.0 %id)
DA476003   .a 735 to 1280 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BX482645   .a 603 to 1249 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
AL121081 melanoma (MeWo cell line) .a 1281 to 1481 1 to 201       201/201
(100 %)
4 diff
(98.1 %id)
DW409943 Liver .a 182 to 506 12 to 336       325/336
(96 %)
8 diff
(97.7 %id)
EC462040 Prostate .a 1834 to 1946 1 to 109       109/109
(100 %)
3 diff
(97.3 %id)
EC472221 Prostate .a 1833 to 1946 1 to 114       114/114
(100 %)
4 diff
(96.5 %id)
EC487227 Prostate .d 4568 to 4683 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
EH349002   .a 2053 to 2141 1 to 89       89/92
(96 %)
6 diff
(93.5 %id)
ES315851 melanoma cell line .d 3782 to 4219 87 to 524       438/524
(83 %)
10 diff
(98.1 %id)
EY198511 intestinal (Lauren) gastric adenocarcinoma, stomach .a 1013 to 1440 428 to 1     Submitted on the opposite strand 428/428
(100 %)
0 diff
(100 %id)
DA484121 brain .a 119 to 684 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA493113 brain .a 66 to 640 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA507485 brain .a 64 to 631 2 to 569   capped   568/569
(99 %)
1 diff
(99.9 %id)
FN114118 breast carcinoma .i-u 29 to 101 1 to 74       74/75
(98 %)
2 diff
(97.4 %id)
GD145447   .a 1690 to 1867 178 to 1     Submitted on the opposite strand 178/184
(96 %)
0 diff
(100 %id)
GD153467   .a 2048 to 2242 1 to 196       196/202
(97 %)
4 diff
(98.1 %id)
GD158811   .a 2048 to 2233 1 to 187   AAA   187/187
(100 %)
3 diff
(98.4 %id)
DA553143   .a 187 to 661 2 to 476   capped   475/475
(100 %)
1 diff
(99.8 %id)
BP236756 coronary artery .a 145 to 736 1 to 592       592/592
(100 %)
15 diff
(97.5 %id)
BQ639250 eye, retina .a 102 to 721 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
AU119748 whole embryo, mainly head .d 3631 to 4328 2 to 700   fully sequenced, capped   699/699
(100 %)
1 diff
(99.9 %id)
AU146009 whole embryo, mainly head .d 4298 to 4743 444 to 1   fully sequenced,   444/444
(100 %)
2 diff
(99.6 %id)
AU098785   .a 105 to 401 1 to 297       297/300
(99 %)
3 diff
(99.0 %id)
AU103390   .a 105 to 154 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP237361 Liver .a 105 to 718 1 to 613       613/624
(98 %)
15 diff
(97.6 %id)
BP240656 Liver .a 115 to 684 1 to 570       570/570
(100 %)
10 diff
(98.3 %id)
BP241314 Liver .a 184 to 748 1 to 565       565/565
(100 %)
4 diff
(99.3 %id)
BJ990078 hepatoblastoma .a 184 to 768 1 to 585       585/585
(100 %)
0 diff
(100 %id)
BJ990079 hepatoblastoma .a 1674 to 2212 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
BP248765 Kidney .e 1 to 581 3 to 583 exact tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
CN481858 eye .a 185 to 788 11 to 614       604/614
(98 %)
7 diff
(98.9 %id)
R14451 whole brain .a 2270 to 2531 1 to 262       262/262
(100 %)
2 diff
(99.3 %id)
R40775 whole brain .a 3436 to 3743 339 to 22   AAA   318/325
(97 %)
12 diff
(96.4 %id)
R36777.
matches multiple genes
whole brain .d 3828 to 4131 1 to 308     also hits gene TTC9 308/344
(89 %)
7 diff
(98.0 %id)
T67197 liver and spleen .d 4509 to 4744 246 to 9       238/246
(96 %)
0 diff
(100 %id)
T67198 liver and spleen .d 4042 to 4388 1 to 354       354/355
(99 %)
10 diff
(97.2 %id)
T84985 liver and spleen .d 4042 to 4455 1 to 432   fully sequenced,   432/432
(100 %)
20 diff
(95.4 %id)
T91776 liver and spleen .d 4428 to 4745 337 to 8   fully sequenced,   330/337
(97 %)
0 diff
(100 %id)
R16521 liver and spleen .d 3959 to 4289 1 to 349       349/382
(91 %)
30 diff
(92.2 %id)
R16818 liver and spleen .d 4538 to 4746 215 to 3       213/215
(99 %)
0 diff
(100 %id)
R11370 liver and spleen .d 4146 to 4483 1 to 354   fully sequenced,   354/354
(100 %)
21 diff
(94.1 %id)
R14868 liver and spleen .d 4453 to 4744 305 to 1   fully sequenced,   305/305
(100 %)
23 diff
(92.5 %id)
R21723 placenta .d 4388 to 4744 378 to 8       371/445
(83 %)
0 diff
(100 %id)
R24877 placenta .d 3827 to 4149 1 to 330       330/330
(100 %)
8 diff
(97.6 %id)
R32436 placenta .d 4509 to 4744 241 to 1       241/242
(99 %)
5 diff
(98.0 %id)
R80219 placenta .a 3429 to 3743 327 to 1       327/332
(98 %)
16 diff
(95.2 %id)
R80325 placenta .a 1973 to 2445 1 to 472       472/475
(99 %)
6 diff
(98.8 %id)
H57170 liver and spleen .d 3692 to 4012 1 to 321     Submitted on the opposite strand 321/332
(96 %)
5 diff
(98.5 %id)
H57247 liver and spleen .d 4628 to 4742 115 to 1     Submitted on the opposite strand 115/115
(100 %)
1 diff
(99.2 %id)
H90278 liver and spleen .d 4163 to 4277 1 to 115       115/115
(100 %)
0 diff
(100 %id)
N76409 liver and spleen .d 4225 to 4539 6 to 319       314/319
(98 %)
6 diff
(98.2 %id)
H96501 melanocyte .d 4270 to 4744 481 to 1       481/481
(100 %)
8 diff
(98.4 %id)
H88990 cochlea, ear .d 4560 to 4724 169 to 6       164/170
(96 %)
0 diff
(100 %id)
H89081 cochlea, ear .d 4225 to 4523 1 to 301       301/351
(85 %)
8 diff
(97.8 %id)
N20463 melanocyte .d 4407 to 4745 354 to 9       346/354
(97 %)
0 diff
(100 %id)
N25490 melanocyte .d 3967 to 4401 1 to 437       437/487
(89 %)
7 diff
(98.6 %id)
N23226 melanocyte .d 4352 to 4743 393 to 1   fully sequenced,   393/393
(100 %)
1 diff
(99.8 %id)
N28807 melanocyte .d 4340 to 4382 1 to 43   fully sequenced,   43/43
(100 %)
0 diff
(100 %id)
N26568 melanocyte .d 4094 to 4743 644 to 1       644/647
(99 %)
24 diff
(96.3 %id)
N33276 melanocyte .d 4319 to 4746 435 to 6       430/435
(98 %)
0 diff
(100 %id)
N44766 melanocyte .d 3966 to 4158 1 to 193       193/196
(98 %)
2 diff
(99.0 %id)
N73491 liver and spleen .d 3692 to 4012 1 to 327     Submitted on the opposite strand 327/424
(77 %)
9 diff
(97.9 %id)
W02498 liver and spleen .d 4299 to 4744 452 to 1     Submitted on the opposite strand 452/639
(70 %)
10 diff
(98.5 %id)
W01020 liver and spleen .d 3797 to 4239 1 to 446       446/446
(100 %)
3 diff
(99.4 %id)
AA677910 liver and spleen .d 4243 to 4746 511 to 2       510/511
(99 %)
0 diff
(100 %id)
AA699438 liver and spleen .d 4294 to 4743 474 to 27   AAA   448/448
(100 %)
7 diff
(98.5 %id)
AA703156 liver and spleen .d 4229 to 4737 503 to 1       503/503
(100 %)
5 diff
(99.1 %id)
AA779381 liver and spleen .d 4230 to 4743 514 to 1       514/514
(100 %)
2 diff
(99.7 %id)
AA164927   .a 1743 to 2233 500 to 1       500/527
(94 %)
13 diff
(97.6 %id)
AA161442.
matches multiple genes
  .a 248 to 759 1 to 509     also hits gene fergeeby 509/520
(97 %)
11 diff
(97.9 %id)
AA204945   .d 4181 to 4707 537 to 1       537/537
(100 %)
16 diff
(97.1 %id)
AA405721.
matches multiple genes
  .d 4207 to 4743 546 to 17   AAA also hits gene PSME2 530/530
(100 %)
11 diff
(98.0 %id)
AA405785   .d 3814 to 4421 1 to 601       601/601
(100 %)
21 diff
(96.6 %id)
AA629260   .d 4202 to 4746 549 to 5       545/549
(99 %)
0 diff
(100 %id)
AA442070   .a 1744 to 2237 494 to 1   fully sequenced,   494/494
(100 %)
2 diff
(99.6 %id)
AA442175   .a 1232 to 1759 1 to 528   fully sequenced,   528/528
(100 %)
9 diff
(98.3 %id)
AA513856 Ewing's sarcoma .d 4578 to 4743 177 to 12   AAA   166/166
(100 %)
0 diff
(100 %id)
AA514549 colon .d 4233 to 4745 524 to 1       524/524
(100 %)
35 diff
(93.4 %id)
AA775984 schizophrenic brain S-11 frontal lobe .f 662 to 872 1 to 211   tiling clone, Submitted on the opposite strand 211/211
(100 %)
2 diff
(99.1 %id)
AA577165 colon, colon tumor RER+ .a 1563 to 1979 427 to 13   AAA   415/415
(100 %)
24 diff
(94.3 %id)
AA613508 colon, colon tumor RER+ .d 1331 to 1661 331 to 1       331/331
(100 %)
1 diff
(99.7 %id)
AA662572 Ewing's sarcoma .d 4473 to 4743 284 to 12   AAA   273/273
(100 %)
2 diff
(99.3 %id)
AA659233   .a 1494 to 2222 726 to 1       726/726
(100 %)
11 diff
(98.5 %id)
AA829629 carcinoid, lung .j-u 97 to 542 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AA826427 carcinoid, lung .j-u 97 to 542 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AA873575 2 pooled tumors (clear cell type), Kidney .d 4137 to 4737 607 to 13   AAA   595/595
(100 %)
25 diff
(95.8 %id)
AA912160 pooled .d 3936 to 4486 1 to 543     Submitted on the opposite strand 543/543
(100 %)
18 diff
(96.7 %id)
AA927872 pooled .d 4264 to 4743 496 to 15   AAA   482/482
(100 %)
13 diff
(97.4 %id)
AA936126 pooled germ cell tumors .d 4239 to 4743 528 to 23   AAA   506/509
(99 %)
9 diff
(98.3 %id)
AI025457   .d 4195 to 4746 554 to 3       552/554
(99 %)
0 diff
(100 %id)
AI041528   .d 4351 to 4711 365 to 29       337/365
(92 %)
0 diff
(100 %id)
AI146521 brain, glioblastoma (pooled) .j-u 1 to 453 11 to 463     Submitted on the opposite strand 453/463
(97 %)
0 diff
(100 %id)
AI146356 brain, glioblastoma (pooled) .j-u 1 to 470 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
AI223213   .d 4250 to 4745 493 to 1       493/513
(96 %)
18 diff
(96.5 %id)
AI214847   .a 1883 to 2236 358 to 1       358/358
(100 %)
4 diff
(98.9 %id)
AI216890   .a 1884 to 2236 353 to 1       353/353
(100 %)
9 diff
(97.5 %id)
AI250907 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1677 to 2233 556 to 1       556/556
(100 %)
1 diff
(99.9 %id)
AI274323 adenocarcinoma, colon .d 4280 to 4743 479 to 13   AAA   467/535
(87 %)
4 diff
(99.3 %id)
AI309631 2 pooled tumors (clear cell type), Kidney .d 4170 to 4737 580 to 12   AAA   569/569
(100 %)
6 diff
(99.0 %id)
AI287834 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 4229 to 4745 516 to 1       516/518
(99 %)
16 diff
(97.0 %id)
AI356632 brain, glioblastoma (pooled) .d 3941 to 4639 695 to 1       695/703
(98 %)
25 diff
(96.5 %id)
AI887970 carcinoid, lung .a 2229 to 2606 378 to 4       375/378
(99 %)
0 diff
(100 %id)
AI457120 colon, moderately-differentiated adenocarcinoma .i-u 124 to 800 674 to 1   tiling clone,   674/764
(88 %)
12 diff
(98.5 %id)
AI625282 adenocarcinoma, Pancreas .d 4365 to 4746 385 to 5       381/390
(97 %)
0 diff
(100 %id)
AI591128 ovary, tumor, 5 pooled (see description) .i-u 1 to 612 1 to 611 exact tiling clone, Submitted on the opposite strand 611/611
(100 %)
5 diff
(99.2 %id)
AI811976 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 4321 to 4745 427 to 1       427/427
(100 %)
21 diff
(95.1 %id)
AI653906 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 2026 to 2313 286 to 1       286/286
(100 %)
13 diff
(95.5 %id)
AI653956 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1589 to 1843 1 to 255     Submitted on the opposite strand 255/255
(100 %)
3 diff
(98.9 %id)
AI633220 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 4021 to 4744 724 to 1       724/724
(100 %)
13 diff
(98.3 %id)
AI677697 pooled .d 3997 to 4746 753 to 5       749/753
(99 %)
0 diff
(100 %id)
AI807782 pooled .d 3993 to 4503 512 to 1       512/512
(100 %)
13 diff
(97.5 %id)
AI828237 adenocarcinoma, Pancreas .d 4063 to 4743 691 to 11   AAA   681/681
(100 %)
21 diff
(97.0 %id)
AI888158 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 4118 to 4743 637 to 12   AAA   626/629
(99 %)
12 diff
(98.1 %id)
AW008472 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 3 to 483 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AI951395 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .d 4225 to 4737 539 to 29   AAA   511/511
(100 %)
5 diff
(99.1 %id)
AW070473 pooled .d 4073 to 4745 672 to 1       672/672
(100 %)
5 diff
(99.3 %id)
AW071034 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .d 3667 to 4259 628 to 37   AAA   592/600
(98 %)
0 diff
(100 %id)
AW294385   .a 2308 to 2648 355 to 16       340/355
(95 %)
0 diff
(100 %id)
AW303656 pooled .i-u 124 to 800 676 to 1       676/683
(98 %)
8 diff
(98.9 %id)
AW769639 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 3917 to 4267 353 to 1       353/353
(100 %)
4 diff
(98.9 %id)
AW769632 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 3950 to 4267 320 to 1       320/320
(100 %)
5 diff
(98.5 %id)
AW771255 Kidney .d 3700 to 4123 1 to 426     Submitted on the opposite strand 426/433
(98 %)
6 diff
(98.7 %id)
BU429272 lymph .d 3920 to 4513 23 to 615       593/615
(96 %)
11 diff
(98.3 %id)
CF137753 lymph .a 102 to 455 8 to 361       354/361
(98 %)
7 diff
(98.1 %id)
CB044540 colon, juvenile granulosa tumor .a 1697 to 2233 553 to 17   AAA   537/537
(100 %)
0 diff
(100 %id)
CB044541 colon, juvenile granulosa tumor .a 74 to 712 11 to 649       639/649
(98 %)
7 diff
(99.0 %id)
BF476510 Prostate .a 1281 to 1627 347 to 1       347/347
(100 %)
0 diff
(100 %id)
BE296984 muscle, rhabdomyosarcoma .a 191 to 787 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
BE407986 choriocarcinoma, placenta .a 226 to 871 1 to 645       645/691
(93 %)
13 diff
(98.2 %id)
BF037674 adenocarcinoma, ovary .d 3523 to 4236 1 to 704       704/759
(92 %)
14 diff
(98.2 %id)
BE902763 choriocarcinoma, placenta .a 217 to 842 1 to 631       631/657
(96 %)
12 diff
(98.2 %id)
BF244527 brain, glioblastoma .d 4046 to 4414 343 to 706       364/935
(38 %)
24 diff
(97.5 %id)
BF210772 bone marrow, from chronic myelogenous leukemia .d 4114 to 4733 1 to 620       620/679
(91 %)
24 diff
(96.5 %id)
BF307809 muscle, rhabdomyosarcoma .a 133 to 773 1 to 642       640/912
(70 %)
28 diff
(97.0 %id)
BF672776 muscle (skeletal) .j-u 319 to 1058 727 to 1 exact tiling clone, Submitted on the opposite strand 727/893
(81 %)
36 diff
(96.0 %id)
BF686246 leiomyosarcoma cell line, uterus .a 108 to 788 1 to 685       685/1130
(60 %)
16 diff
(98.6 %id)
BF797836 lymph, lymphoma, cell line .a 1890 to 2233 23 to 367   AAA   345/367
(94 %)
6 diff
(98.4 %id)
BF797433 lymph, lymphoma, cell line .d 4040 to 4745 1 to 705       705/828
(85 %)
11 diff
(98.7 %id)
BF797350 lymph, lymphoma, cell line .d 4040 to 4659 1 to 640   AAA   640/869
(73 %)
25 diff
(97.2 %id)
BG110272 Bone, osteosarcoma, cell line .d 3702 to 4347 1 to 644       644/644
(100 %)
3 diff
(99.6 %id)
BG179064 adenocarcinoma, cell line, Prostate .d 3851 to 4625 1 to 749       749/909
(82 %)
50 diff
(94.5 %id)
BG165768 hypernephroma, cell line, Kidney .a 1033 to 1803 15 to 781       767/932
(82 %)
47 diff
(95.0 %id)
BG254202 adenocarcinoma, cell line, Prostate .a 1624 to 2276 1 to 663       663/941
(70 %)
26 diff
(97.3 %id)
BG257038 embryonal carcinoma, cell line, testis .a 2166 to 2849 7 to 683       677/705
(96 %)
15 diff
(97.9 %id)
BG492856 lung, mucoepidermoid carcinoma .d 3766 to 4386 1 to 621       621/629
(98 %)
14 diff
(97.8 %id)
BG502680 embryonal carcinoma, testis .d 3593 to 4304 1 to 712       712/712
(100 %)
6 diff
(99.2 %id)
BG528509 adenocarcinoma, Prostate .d 3285 to 4025 1 to 748       748/966
(77 %)
34 diff
(96.5 %id)
BG763293 melanotic melanoma, high MDR (cell line), skin .a 1384 to 2102 1 to 729       729/781
(93 %)
22 diff
(97.2 %id)
BG826372 muscle, rhabdomyosarcoma .a 171 to 936 1 to 771       771/916
(84 %)
10 diff
(99.0 %id)
BI087809 cervix .a 203 to 927 1 to 748       744/748
(99 %)
37 diff
(95.1 %id)
BM011718 brain, neuroblastoma, cell line .a 134 to 871 1 to 746       746/788
(94 %)
13 diff
(98.4 %id)
BM012534 brain, neuroblastoma, cell line .a 134 to 760 1 to 627       627/627
(100 %)
3 diff
(99.6 %id)
BM466392 eye, retinoblastoma .a 101 to 939 13 to 860       848/1053
(80 %)
16 diff
(98.5 %id)
BM467399 lymph, lymphoma, cell line .f 1 to 736 3 to 744 S164G tiling clone,   744/1090
(68 %)
13 diff
(98.9 %id)
BM806840 lymph, lymphoma, cell line .a 1861 to 2908 1 to 1059       1059/1062
(99 %)
53 diff
(95.1 %id)
BM804121 eye, retinoblastoma .a 1092 to 2012 1 to 922       922/1091
(84 %)
27 diff
(97.6 %id)
BI963012 Islets of Langerhans, Pancreas .a 1237 to 1762 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
BI966822 Islets of Langerhans, Pancreas .a 1684 to 2237 555 to 1       555/555
(100 %)
1 diff
(99.9 %id)
CK903615 Islets of Langerhans, Pancreas .a 1737 to 2237 502 to 1       502/502
(100 %)
2 diff
(99.7 %id)
CK903616 Islets of Langerhans, Pancreas .a 1221 to 1802 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BM988691 lung, Metastatic Chondrosarcoma .d 4053 to 4743 710 to 19   AAA   692/692
(100 %)
1 diff
(99.9 %id)
BQ000651 Fibrosarcoma .d 4013 to 4743 748 to 19   AAA   730/730
(100 %)
3 diff
(99.6 %id)
BQ072126 brain, neuroblastoma, cell line .a 205 to 1087 1 to 886       886/1027
(86 %)
19 diff
(98.2 %id)
BQ229606 embryonal carcinoma, cell line, testis .a 208 to 1126 1 to 925       925/925
(100 %)
10 diff
(99.0 %id)
BU184858 epithelioid carcinoma, Pancreas .a 141 to 824 1 to 691       691/890
(77 %)
12 diff
(98.7 %id)
BU181806 eye, retinoblastoma .a 1697 to 2546 1 to 853       853/858
(99 %)
9 diff
(99.0 %id)
BU165960 melanotic melanoma, skin .a 1670 to 2562 1 to 896       896/897
(99 %)
15 diff
(98.4 %id)
BQ644173 hepatocellular carcinoma, cell line, Liver .a 128 to 932 1 to 806       806/926
(87 %)
9 diff
(99.1 %id)
BQ942758 epidermoid carcinoma, cell line, lung .a 213 to 1172 1 to 969       967/974
(99 %)
22 diff
(97.8 %id)
BU598039 mixed (pool of 40 RNAs) .d 3756 to 4289 1 to 537       537/877
(61 %)
11 diff
(98.8 %id)
BQ924096 epidermoid carcinoma, cell line, lung .a 213 to 758 1 to 549       549/1377
(39 %)
9 diff
(99.4 %id)
BQ946482 leiomyosarcoma, uterus .c 1 to 928 1 to 927 V53G P94S Q95S E96G Q97T ... tiling clone,   927/928
(99 %)
12 diff
(98.8 %id)
BQ932568 leiomyosarcoma, uterus .a 1462 to 2248 1 to 790       790/971
(81 %)
11 diff
(98.9 %id)
BU600983 mixed (pool of 40 RNAs) .d 4227 to 4746 1 to 520       520/525
(99 %)
4 diff
(99.3 %id)
BU940931 mixed (pool of 40 RNAs) .a 1622 to 2173 1 to 555       555/863
(64 %)
25 diff
(97.2 %id)
CX167016 human embryonic stem cells differentiated toan early endodermal cell type .a 2327 to 3075 22 to 769       748/769
(97 %)
6 diff
(99.3 %id)
CD657552 Embryonic Stem cells .d 1423 to 2148 10 to 732       723/821
(88 %)
11 diff
(98.7 %id)
DA607330   .a 180 to 718 2 to 544   capped   543/552
(98 %)
8 diff
(98.6 %id)
DA610715   .a 172 to 745 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA614593   .a 185 to 766 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DA615966   .a 634 to 1209 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA618401   .a 2246 to 2811 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
TI_59380892   .a 134 to 871 100 to 845       746/788
(94 %)
13 diff
(98.4 %id)
TI_59381751   .a 134 to 760 61 to 687       627/627
(100 %)
3 diff
(99.6 %id)
BP283631 bone marrow .a 186 to 766 1 to 581       581/581
(100 %)
18 diff
(97.0 %id)
CB164689 Liver .d 3789 to 4312 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
BY995805   .a 2143 to 2806 23 to 683       661/683
(96 %)
6 diff
(99.2 %id)
NM_002703.3   .a 1 to 3743 1 to 3743   RefSeq, AAA   3743/3743
(100 %)
0 diff
(100 %id)
BP312291 brain .a 186 to 604 1 to 419       419/581
(72 %)
10 diff
(98.3 %id)
DC365664   .a 189 to 729 1 to 542       542/542
(100 %)
3 diff
(99.5 %id)
DA692646   .a 125 to 682 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA703993   .a 149 to 679 2 to 533   capped   532/532
(100 %)
2 diff
(99.7 %id)
DA724808   .a 66 to 621 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
DA729617   .a 190 to 718 2 to 531   capped   530/539
(98 %)
3 diff
(99.5 %id)
AU127201   .d 3688 to 4368 2 to 693   fully sequenced, capped   692/692
(100 %)
3 diff
(99.6 %id)
AU149870   .d 4338 to 4696 359 to 1   fully sequenced,   359/359
(100 %)
1 diff
(99.8 %id)
AU129260   .a 1629 to 2099 2 to 473   capped   472/472
(100 %)
4 diff
(99.2 %id)
AU151421   .a 3159 to 3743 581 to 1       581/585
(99 %)
10 diff
(98.3 %id)
AU131257   .d 1 to 773 2 to 783   tiling clone, capped   782/789
(99 %)
12 diff
(98.5 %id)
AU153028   .d 4242 to 4743 498 to 1       498/498
(100 %)
13 diff
(97.4 %id)
AU132804   .a 66 to 879 2 to 814   capped   813/814
(99 %)
8 diff
(99.1 %id)
AU154262   .a 1645 to 2233 592 to 1       592/592
(100 %)
8 diff
(98.7 %id)
DA746826   .a 156 to 719 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA755459   .a 189 to 721 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
DA756076   .a 47 to 615 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA756198   .a 44 to 531 2 to 491   tiling clone, capped   490/490
(100 %)
3 diff
(99.4 %id)
DA797021 brain .a 74 to 638 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA800066 brain .a 119 to 668 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA807294 brain .a 115 to 670 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA809890 brain .a 119 to 670 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BP313855 mammary gland .a 74 to 644 14 to 585       572/585
(97 %)
6 diff
(99.0 %id)
AU134505 ovary, tumor tissue .a 1782 to 2499 2 to 717   capped   716/716
(100 %)
3 diff
(99.6 %id)
AU155465 ovary, tumor tissue .a 3210 to 3743 537 to 1   tiling clone,   537/542
(99 %)
9 diff
(98.4 %id)
DA861261 placenta .a 67 to 655 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA861659 placenta .a 119 to 663 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BP325958 prostata .h 2 to 574 1 to 574 S104F A115S V116F R117P G121* tiling clone,   574/584
(98 %)
12 diff
(98.0 %id)
BP326273 prostata .a 537 to 1116 1 to 581       581/582
(99 %)
3 diff
(99.5 %id)
DA885477   .a 66 to 634 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BP330003 rectum .d 3679 to 4258 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
TI_1948145804   .a 202 to 869 127 to 793       667/1289
(51 %)
23 diff
(98.3 %id)
TI_1948145805   .a 202 to 1087 121 to 1007       887/1257
(70 %)
16 diff
(98.8 %id)
TI_1948145806   .a 862 to 1755 1015 to 130       886/1166
(75 %)
20 diff
(98.3 %id)
TI_1948145807   .a 925 to 1755 971 to 137       835/1682
(49 %)
22 diff
(98.7 %id)
TI_1948146114   .a 202 to 861 126 to 786       661/1309
(50 %)
25 diff
(98.1 %id)
TI_1948146115   .a 202 to 1216 124 to 1132       1009/1238
(81 %)
37 diff
(97.1 %id)
TI_1948146116   .a 779 to 1755 1099 to 128       974/1301
(74 %)
19 diff
(98.6 %id)
TI_1948146117   .a 862 to 1755 1017 to 130       890/1441
(61 %)
21 diff
(98.6 %id)
TI_1948146448   .a 202 to 871 118 to 786       669/1292
(51 %)
16 diff
(98.8 %id)
TI_1948146449   .a 202 to 1224 124 to 1140       1017/1247
(81 %)
41 diff
(96.8 %id)
TI_1948146450   .a 863 to 1755 1023 to 129       895/1267
(70 %)
14 diff
(98.9 %id)
TI_1948146451   .a 861 to 1755 1026 to 139       888/1402
(63 %)
21 diff
(98.6 %id)
TI_1948146757   .a 202 to 856 128 to 781       654/1329
(49 %)
23 diff
(98.3 %id)
TI_1948146758   .a 202 to 1218 123 to 1129       1007/1235
(81 %)
39 diff
(96.9 %id)
TI_1948146759   .a 775 to 1755 1100 to 128       973/1264
(76 %)
28 diff
(97.8 %id)
TI_1948146760   .a 932 to 1755 963 to 138       826/1477
(55 %)
19 diff
(98.8 %id)
DA917415 small intestine .a 187 to 743 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA988970 synovial membrane tissue from rheumatioidarthritis .a 67 to 647 2 to 582   capped   581/581
(100 %)
2 diff
(99.7 %id)
BP348541 brain .a 1319 to 1898 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
DA997735   .a 69 to 634 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DN997784 breast cancer, Mammary gland (cancer tissue) .a 208 to 875 9 to 675       667/675
(98 %)
11 diff
(98.4 %id)
DN995448 breast cancer, Mammary gland (cancer tissue) .a 190 to 871 1 to 684       684/689
(99 %)
12 diff
(98.3 %id)
BM146370 leukopheresis .a 92 to 228 1 to 137       137/169
(81 %)
4 diff
(97.7 %id)
BM151901 leukopheresis .a 164 to 541 1 to 377       377/377
(100 %)
13 diff
(96.6 %id)
BM152458 leukopheresis .a 103 to 331 1 to 229       229/284
(80 %)
3 diff
(99.0 %id)
BP357483 mammary gland .a 182 to 761 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
BP359654 mammary gland .a 186 to 767 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB016455 esophageal, tumor tissue .a 187 to 707 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
DB016652 esophageal, tumor tissue .a 69 to 645 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DB039655 testis .a 45 to 596 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB062080 testis .a 69 to 624 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB068385 testis .a 106 to 651 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DB071308 testis .a 185 to 682 2 to 503   capped   502/503
(99 %)
6 diff
(98.9 %id)
DB077178 testis .h 1 to 562 2 to 564   tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
DB102510 thymus .a 51 to 599 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DB117157 thymus .a 69 to 604 2 to 539   capped   538/541
(99 %)
4 diff
(99.3 %id)
DB145450 thymus .a 187 to 684 2 to 501   capped   500/500
(100 %)
3 diff
(99.4 %id)
TI_149309977   .d 4083 to 4743 748 to 87   AAA   662/966
(68 %)
1 diff
(99.9 %id)
TI_154062789   .a 856 to 1646 857 to 70   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 788/1081
(72 %)
9 diff
(99.2 %id)
TI_154150317   .d 3920 to 4651 94 to 821       728/744
(97 %)
16 diff
(97.9 %id)
TI_154167381   .a 102 to 595 81 to 575       495/496
(99 %)
10 diff
(98.0 %id)
DB201593 trachea .a 69 to 663 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DB218241 trachea .a 119 to 657 2 to 541   capped   540/540
(100 %)
4 diff
(99.3 %id)
DB222870 trachea .a 187 to 755 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DB228311 trachea .a 117 to 684 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB230938 trachea .a 64 to 658 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DB232230 trachea .a 82 to 670 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
DB235734 trachea .a 190 to 728 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
U00238   .a 153 to 3743 1 to 3595 V369I tiling clone, AAA   3595/3595
(100 %)
9 diff
(99.8 %id)
BQ025032 placenta .d 4249 to 4743 514 to 19   AAA   496/496
(100 %)
12 diff
(97.6 %id)
BU688329 lung .d 4083 to 4743 679 to 18   AAA   662/670
(98 %)
1 diff
(99.9 %id)
BU632328 cell lines, Chondrosarcoma .d 4126 to 4743 637 to 19   AAA   619/619
(100 %)
4 diff
(99.4 %id)
CA421287 Bone, Enchondroma cell line .a 933 to 1647 713 to 1       713/713
(100 %)
5 diff
(99.3 %id)
BU627914 Bone, Enchondroma cell line .a 937 to 1647 710 to 1   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 710/710
(100 %)
8 diff
(98.9 %id)
CA429129 Cell Line, Chondrosarcoma .d 3925 to 4657 1 to 734     Submitted on the opposite strand 734/734
(100 %)
3 diff
(99.6 %id)
DB274141 uterus .a 64 to 613 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB276307 uterus .a 121 to 657 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DB284469 uterus .a 184 to 707 2 to 526   capped   525/525
(100 %)
1 diff
(99.9 %id)
BP383633   .a 2152 to 2653 1 to 499       499/499
(100 %)
5 diff
(99.0 %id)
AU142764   .a 189 to 977 2 to 795   capped   794/794
(100 %)
11 diff
(98.7 %id)
AU159995   .a 1814 to 2314 505 to 1       505/509
(99 %)
15 diff
(97.1 %id)
AU143306   .b 1 to 689 6 to 693   tiling clone, capped   692/721
(95 %)
7 diff
(99.1 %id)
AU160414   .b 1304 to 1800 498 to 1   tiling clone,   498/545
(91 %)
9 diff
(98.4 %id)
BP381024   .a 1465 to 2194 1 to 729       729/730
(99 %)
17 diff
(97.7 %id)
AU127201   .d 3688 to 4368 2 to 693   fully sequenced, capped   692/692
(100 %)
3 diff
(99.6 %id)
AU149870   .d 4338 to 4696 359 to 1   fully sequenced,   359/359
(100 %)
1 diff
(99.8 %id)
AU129260 NT2RP2005189 PPAT.aAug10 2099 473 NT2RP2005189     472 4
AU151421 NT2RP2005189 PPAT.aAug10 3743 1 NT2RP2005189     581 10
AU131257 NT2RP3002250 PPAT.dAug10 773 783 NT2RP3002250     782 12
AU153028 NT2RP3002250 PPAT.dAug10 4743 1 NT2RP3002250     498 13
AU132804 NT2RP4000585 PPAT.aAug10 879 814 NT2RP4000585     813 8
AU154262 NT2RP4000585 PPAT.aAug10 2233 1 NT2RP4000585     592 8
DA746826 NT2RP7011912 PPAT.aAug10 719 565 NT2RP7011912     564 1
DA755459 NT2RP8001809 PPAT.aAug10 721 535 NT2RP8001809     534 2
DA756076 NT2RP8002695 PPAT.aAug10 615 570 NT2RP8002695     569 3
DA756198 NT2RP8002890 PPAT.aAug10 531 491 NT2RP8002890     490 3
DA797021 OCBBF3000048 PPAT.aAug10 638 566 OCBBF3000048     565 0
DA800066 OCBBF3003918 PPAT.aAug10 668 551 OCBBF3003918     550 0
DA807294 OCBBF3022902 PPAT.aAug10 670 559 OCBBF3022902     558 2
DA809890 OCBBF3026265 PPAT.aAug10 670 554 OCBBF3026265     553 1
BP313855 OFR04656 PPAT.aAug10 644 585 OFR04656     572 6
AU134505 OVARC1002098 PPAT.aAug10 2499 717 OVARC1002098     716 3
AU155465 OVARC1002098 PPAT.aAug10 3743 1 OVARC1002098     537 9
DA861261 PLACE7013932 PPAT.aAug10 655 590 PLACE7013932     589 1
DA861659 PLACE7014457 PPAT.aAug10 663 546 PLACE7014457     545 1
BP325958 PRS00705 PPAT.hAug10 574 574 PRS00705     574 12
BP326273 PRS02119 PPAT.aAug10 1116 581 PRS02119     581 3
DA885477 PUAEN2005554 PPAT.aAug10 634 570 PUAEN2005554     569 1
BP330003 RCT05031 PPAT.dAug10 4258 582 RCT05031     582 3
TI_1948145804 SC_11076_1_D7 PPAT.aAug10 869 793 SC_11076_1_D7     667 23
TI_1948145805 SC_11076_1_D7__1 PPAT.aAug10 1087 1007 SC_11076_1_D7__1     887 16
TI_1948145806 SC_11076_1_D7__2 PPAT.aAug10 1755 130 SC_11076_1_D7__2     886 20
TI_1948145807 SC_11076_1_D7__3 PPAT.aAug10 1755 137 SC_11076_1_D7__3     835 22
TI_1948146114 SC_11076_2_D7 PPAT.aAug10 861 786 SC_11076_2_D7     661 25
TI_1948146115 SC_11076_2_D7__1 PPAT.aAug10 1216 1132 SC_11076_2_D7__1     1009 37
TI_1948146116 SC_11076_2_D7__2 PPAT.aAug10 1755 128 SC_11076_2_D7__2     974 19
TI_1948146117 SC_11076_2_D7__3 PPAT.aAug10 1755 130 SC_11076_2_D7__3     890 21
TI_1948146448 SC_11076_3_D7 PPAT.aAug10 871 786 SC_11076_3_D7     669 16
TI_1948146449 SC_11076_3_D7__1 PPAT.aAug10 1224 1140 SC_11076_3_D7__1     1017 41
TI_1948146450 SC_11076_3_D7__2 PPAT.aAug10 1755 129 SC_11076_3_D7__2     895 14
TI_1948146451 SC_11076_3_D7__3 PPAT.aAug10 1755 139 SC_11076_3_D7__3     888 21
TI_1948146757 SC_11076_4_D7 PPAT.aAug10 856 781 SC_11076_4_D7     654 23
TI_1948146758 SC_11076_4_D7__1 PPAT.aAug10 1218 1129 SC_11076_4_D7__1     1007 39
TI_1948146759 SC_11076_4_D7__2 PPAT.aAug10 1755 128 SC_11076_4_D7__2     973 28
TI_1948146760 SC_11076_4_D7__3 PPAT.aAug10 1755 138 SC_11076_4_D7__3     826 19
DA917415 SMINT2002077 PPAT.aAug10 743 560 SMINT2002077     559 2
DA988970 SYNOV4000142 PPAT.aAug10 647 582 SYNOV4000142     581 2
BP348541 SZR00802 PPAT.aAug10 1898 583 SZR00802     583 4
DA997735 T1ESE2001746 PPAT.aAug10 634 567 T1ESE2001746     566 0
DN997784 TC106896 PPAT.aAug10 875 675 TC106896     667 11
DN997784 TC106896 PPAT.aAug10 875 675 TC106896     667 11
DN995448 TC118472 PPAT.aAug10 871 684 TC118472     684 12
DN995448 TC118472 PPAT.aAug10 871 684 TC118472     684 12
BM146370 TCAAP4555 PPAT.aAug10 228 137 TCAAP4555     137 4
BM151901 TCBAP1135__4 PPAT.aAug10 541 377 TCBAP1135__4     377 13
BM152458 TCBAP9072 PPAT.aAug10 331 229 TCBAP9072     229 3
BP357483 TDR03321 PPAT.aAug10 761 580 TDR03321     580 1
BP359654 TDR09284 PPAT.aAug10 767 582 TDR09284     582 1
DB016455 TESOP2005775 PPAT.aAug10 707 522 TESOP2005775     521 0
DB016652 TESOP2006017 PPAT.aAug10 645 578 TESOP2006017     577 1
DB039655 TESTI2026242 PPAT.aAug10 596 553 TESTI2026242     552 0
DB062080 TESTI4002112 PPAT.aAug10 624 557 TESTI4002112     556 1
DB068385 TESTI4010303 PPAT.aAug10 651 548 TESTI4010303     547 1
DB071308 TESTI4014081 PPAT.aAug10 682 503 TESTI4014081     502 6
DB077178 TESTI4021708 PPAT.hAug10 562 564 TESTI4021708     563 2
DB102510 THYMU2001772 PPAT.aAug10 599 550 THYMU2001772     549 1
DB117157 THYMU2023748 PPAT.aAug10 604 539 THYMU2023748     538 4
DB145450 THYMU3020359 PPAT.aAug10 684 501 THYMU3020359     500 3
TI_149309977 TI_149309977 PPAT.dAug10 4743 87 TI_149309977     662 1
TI_154062789 TI_154062789 PPAT.aAug10 1646 70 TI_154062789   Anomalous_clone 788 9
TI_154150317 TI_154150317 PPAT.dAug10 4651 821 TI_154150317     728 16
TI_154167381 TI_154167381 PPAT.aAug10 595 575 TI_154167381     495 10
DB201593 TRACH2011262 PPAT.aAug10 663 596 TRACH2011262     595 0
DB218241 TRACH3007925 PPAT.aAug10 657 541 TRACH3007925     540 4
DB222870 TRACH3013977 PPAT.aAug10 755 570 TRACH3013977     569 0
DB228311 TRACH3021090 PPAT.aAug10 684 569 TRACH3021090     568 1
DB230938 TRACH3024396 PPAT.aAug10 658 596 TRACH3024396     595 1
DB232230 TRACH3026076 PPAT.aAug10 670 590 TRACH3026076     589 0
DB235734 TRACH3030789 PPAT.aAug10 728 540 TRACH3030789     539 1
U00238 U00238 PPAT.aAug10 3743 3595 U00238     3595 9
BQ025032 UI-1-BB1p-atq-d-02-0-UI PPAT.dAug10 4743 19 UI-1-BB1p-atq-d-02-0-UI     496 12
BU688329 UI-CF-EC1-aea-c-12-0-UI PPAT.dAug10 4743 18 UI-CF-EC1-aea-c-12-0-UI     662 1
BU632328 UI-H-FE1-beb-j-23-0-UI PPAT.dAug10 4743 19 UI-H-FE1-beb-j-23-0-UI     619 4
BU632328 UI-H-FE1-beb-j-23-0-UI PPAT.dAug10 4743 19 UI-H-FE1-beb-j-23-0-UI     619 4
CA421287 UI-H-FG0-bct-p-16-0-UI PPAT.aAug10 1647 1 UI-H-FG0-bct-p-16-0-UI     713 5
CA421287 UI-H-FG0-bct-p-16-0-UI PPAT.aAug10 1647 1 UI-H-FG0-bct-p-16-0-UI     713 5
BU627914 UI-H-FG0-bdd-j-07-0-UI PPAT.aAug10 1647 1 UI-H-FG0-bdd-j-07-0-UI   Anomalous_clone 710 8
BU627914 UI-H-FG0-bdd-j-07-0-UI PPAT.aAug10 1647 1 UI-H-FG0-bdd-j-07-0-UI   Anomalous_clone 710 8
CA429129 UI-H-FH1-bfh-k-06-0-UI PPAT.dAug10 4657 734 UI-H-FH1-bfh-k-06-0-UI Inverted   734 3
CA429129 UI-H-FH1-bfh-k-06-0-UI PPAT.dAug10 4657 734 UI-H-FH1-bfh-k-06-0-UI Inverted   734 3
DB274141 UTERU2037049 PPAT.aAug10 613 551 UTERU2037049     550 1
DB276307 UTERU3001666 PPAT.aAug10 657 539 UTERU3001666     538 2
DB284469 UTERU3012391 PPAT.aAug10 707 526 UTERU3012391     525 1
BP383633 w1822 PPAT.aAug10 2653 499 w1822     499 5
AU142764 Y79AA1000842 PPAT.aAug10 977 795 Y79AA1000842     794 11
AU159995 Y79AA1000842 PPAT.aAug10 2314 1 Y79AA1000842     505 15
AU143306 Y79AA1001715 PPAT.bAug10 689 693 Y79AA1001715     692 7
AU160414 Y79AA1001715 PPAT.bAug10 1800 1 Y79AA1001715     498 9
BP381024 Zrv6c648 PPAT.aAug10 2194 729 Zrv6c648     729 17
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u, .k-u, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC